Irish biotech firm wins €3m in bid to push diabetes breakthrough over line
Patented peptide which normalises blood sugars now mobilised in race against global epidemic
Biotech and R&D company Nuritas has secured funding to push ahead with an ingredient that potentially halts the inexorable slide into diabetes of pre-diabetic patients.
The scientifically validated and patent-filed peptide represents a major breakthrough in the battle to prevent type two diabetes.
The revolutionary ingredient is sourced from nature and will stand alone as...
Subscribe from just €1 for the first month!
With any subscription you will have access to
Unlimited multi-device access to our iPad, iPhone and Android Apps
Unlimited access to our eReader library
Exclusive daily insight and opinion seven days a week
Create alerts to never miss a subject that matters to you
Get access to exclusive offers for subscribers on gifts and experiences
Get content from Business Post, Business Post Magazines, Connected, Tatler and Food & Wine
Anton Savage: If it doesn’t fit, get out the drillbit
Fitting out your kitchen isn’t for everyone, but it brings out the inner thrillseeker in some of us
Aidan Regan: Fiscal deficit is not a concern, but we must widen the tax base
What should matter to us most of all is the reliability of the revenue stream that funds the state
Elaine Byrne: FG’s knives come out behind a veil of gentlemanly conduct
The strange dynamic between Leo Varadkar, Simon Coveney and Simon Harris has curious echoes of the 2017 Fine Gael leadership race
John Walsh: Going electric comes with potential pitfalls as well as benefits
Sales of electric cars continue to rise and rise, but it’s time to start planning now for the threats of increased congestion and reduced revenue